- Home
- INFU vs MOLN Comparison
INFU vs MOLN Comparison
Compare INFU & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INFU | MOLN |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | Switzerland |
| Employees | 473 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.1M | 158.9M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | INFU | MOLN |
|---|---|---|
| Price | $9.54 | $4.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $15.00 | $8.38 |
| AVG Volume (30 Days) | ★ 110.3K | 3.6K |
| Earning Date | 05-07-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $2.89 | N/A |
| Revenue Next Year | $7.66 | $318.52 |
| P/E Ratio | $31.29 | ★ N/A |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $4.61 | $3.36 |
| 52 Week High | $11.04 | $5.36 |
Technical Indicators
Market Signals| Indicator | INFU | MOLN |
|---|---|---|
| Relative Strength Index (RSI) | 54.53 | 34.20 |
| Support Level | $8.52 | $4.04 |
| Resistance Level | $9.83 | $4.07 |
| Average True Range (ATR) | 0.36 | 0.27 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 60.22 | 0.00 |
Price Performance
Historical ComparisonAbout INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.